Peptidase sequences for human rhinovirus 33
>MER0185112 - rhinovirus picornain 2A [C03.021] peptidase unit: 854-1001 ( active site residue(s): 873,890,961 ) (human rhinovirus 33) (Source: EMBL nucleotide FJ445128) 1 MGAQVSRQNVGTHSTQNAVSNGSSLNYFNINYFKDAASSGASKLEFSQDPSKFTDPVKDV 60 61 LEKGIPTLQSPTVEACGYSDRIIQITRGDSTITSQDVANAVVGYGVWPHYLTPQDATAID 120 121 KPSRPDTSSNRFYTLASKEWDFNSKGWWWKLPDALKDMGIFGENMFYHFLGRSGYTVHVQ 180 181 CNASKFHQGTLIVAMIPEHQLASATTGNATAGYNLTHPGEAGRDVSPKTRENIDKQPSDD 240 241 AWLNFDGTLLGNITVYPHQLINLRSNNSATIIVPYVNAVPMDSMLRHNNWSLVIIPICPL 300 301 ESVPASTVPITISISPMCAEFSGARAAARNQGLPVFITPGSGQFMTTDDFQSPSALPWFH 360 361 PTREISIPGQVKNLVELCQIDTLIPINSTTANNDNTSIYTVTLEKQTNLAQEVFAIKVDI 420 421 ASNPLATTLIGEIASYFTHWTGSVRFSFLFCGTANTTLKLLLAYTPPGIRKPISRKEAML 480 481 GTHVVWDVGLQSTMSMVVPWVSASHFRNTTPDTYSLAGYVTCWYQTSLVVPSSTPITAKM 540 541 LCFVSGCKDFCLRMARDTNLHLQSGIITQNPVENYIEEVLNEVLVVPNIRESQATTSNSA 600 601 PALDAAETGHTNNVQPEDMIETRYVQTSQTLDEMSVESFLGRSGCIHMSKLVVKYEDYNE 660 661 KKNFMTWKINLQEMAQIRRKFEMFTYARFDSEITLVPSIAAQGDDVGHVVMQYMYVPPGA 720 721 PAPEKRDDYTWQSGTNASVFWQYGQTYPRFSLPFLSIASAYYMFYDGYDGDQPNSRYGNM 780 781 VTNDMGTLCSRIVTDNHKHPIEVTTRVYHKAKHVKVWCPRPPRAVEYTHTHVTNYKSTTR 840 841 EVKTAIRPRATIKTAGPSDMYVHVGNLIYRNLHLFNSDIHDSISVSYSSDLVIYRTNTTG 900 901 DDYIPTCDCTDATYFCKHKNRYYPIKVTSHDWYEIQESEYYPKHIQYNLLIGEGPCEPGD 960 961 CGGKLLCKHGVIGIITAGGEGHVAFIDLRHFHCAEEQGITDYIHMLGEAFGSGFVDSVKD 1020 1021 QINAINPINNISRKIVKWILRIISAMVVIIRNSSDPQTIIATLTLIGCSGSPWRFLKEKF 1080 1081 CKWTQLNYIHKESDSWLKKFTEMCNAARGLEWIGNKISKFIEWMKSMLPQAQLKIKYLNE 1140 1141 LKKLNLLEKQIEHLRIADSSTQEKIKCEIDTLHDLSCKFLPLYASEAKRIKVLYNKCNVI 1200 1201 IKQKKRCEPVAVVIHGEPGAGKSMTTNFLARMITNDSDIYSLPPDPKYFDGYDQQSVVIM 1260 1261 DDIMQNPSGDDMTLFCQMVSSVTFIPPMADLPDKGKPFDSRFVLCSTNHSMLAPPTITSL 1320 1321 PAMNRRFYLDLDIVVSEKYKDQQGKLNVAAAFQPCDVNAKIGNARCCPFICGKAVMFKDR 1380 1381 NTCQSYTLAQVYNHILEEDRRRRQVVDVMSAIFQGPISLEXPPPAAISDLLQSVRTPEVI 1440 1441 KYCEDNKWIIPAGCRIERDLNIANTIITIIANVISISGIIYVIYKLFCTLQGPYSGEPKQ 1500 1501 RTKIPERRVVAQGPEEEFGRSLIKHNSCVVTTQNGKFTGLGIYDRTIIIPTHADPGKEVQ 1560 1561 IDGISTKVEDSYDLYNKDGIKLEITVLKLQRNEKFRDIRKYIPEKEDDYPECNLALSANQ 1620 1621 PETTIISVGDVVSYGNILLSGNQTARMLKYNYPTKSGYCGGILYKIGQVLGIHVGGNGRD 1680 1681 GFAAMLLRSYFSETQGQITISKPVVELGLPSIHTPSKTKLQPSVFHDVFPGSKEPAVLSD 1740 1741 NDPRLEVDFKQALFSKYKGNNECAMNEHIKVAVSHYSAQLHTLDVDPRPITVEDSVFGVE 1800 1801 GLEALDLNTSAGYPYVTMGIKKKDLIDNRAKDLTKLKIAMDKYGVDLPMVTFLKDELRKK 1860 1861 EKISAGKTRVIEASSVNDTVLFRSVYGNLFSKFHLNPGIITGSAVGCDPETFWSKIPVML 1920 1921 DGECIMAFDYTNYDGSIHPVWFDALKLVLANLSFRTDLIDRLCKSKHIFKGTYYEVEGGV 1980 1981 PSGCSGTSIFNTMINNVIIRTLVLDAYKNIDLDKLKIIAYGDDVIFSYKYQLDMEAIALE 2040 2041 GVKYGLTITPADKSSIFKKLDYSNITFLKRGFRQDEKHNFLIHPTFPIDEIHESIRWTKK 2100 2101 PSQMQEHVLSLCHLMWHNGRDVYTQFERRIRSVSAGRALYIPPYDLLLHEWYEKF 2155 >MER0185113 - human rhinovirus 2-type picornain 3C [C03.007] peptidase unit: 1513-1695 ( active site residue(s): 1552,1583,1659 ) (human rhinovirus 33) (Source: EMBL nucleotide FJ445128) 1 MGAQVSRQNVGTHSTQNAVSNGSSLNYFNINYFKDAASSGASKLEFSQDPSKFTDPVKDV 60 61 LEKGIPTLQSPTVEACGYSDRIIQITRGDSTITSQDVANAVVGYGVWPHYLTPQDATAID 120 121 KPSRPDTSSNRFYTLASKEWDFNSKGWWWKLPDALKDMGIFGENMFYHFLGRSGYTVHVQ 180 181 CNASKFHQGTLIVAMIPEHQLASATTGNATAGYNLTHPGEAGRDVSPKTRENIDKQPSDD 240 241 AWLNFDGTLLGNITVYPHQLINLRSNNSATIIVPYVNAVPMDSMLRHNNWSLVIIPICPL 300 301 ESVPASTVPITISISPMCAEFSGARAAARNQGLPVFITPGSGQFMTTDDFQSPSALPWFH 360 361 PTREISIPGQVKNLVELCQIDTLIPINSTTANNDNTSIYTVTLEKQTNLAQEVFAIKVDI 420 421 ASNPLATTLIGEIASYFTHWTGSVRFSFLFCGTANTTLKLLLAYTPPGIRKPISRKEAML 480 481 GTHVVWDVGLQSTMSMVVPWVSASHFRNTTPDTYSLAGYVTCWYQTSLVVPSSTPITAKM 540 541 LCFVSGCKDFCLRMARDTNLHLQSGIITQNPVENYIEEVLNEVLVVPNIRESQATTSNSA 600 601 PALDAAETGHTNNVQPEDMIETRYVQTSQTLDEMSVESFLGRSGCIHMSKLVVKYEDYNE 660 661 KKNFMTWKINLQEMAQIRRKFEMFTYARFDSEITLVPSIAAQGDDVGHVVMQYMYVPPGA 720 721 PAPEKRDDYTWQSGTNASVFWQYGQTYPRFSLPFLSIASAYYMFYDGYDGDQPNSRYGNM 780 781 VTNDMGTLCSRIVTDNHKHPIEVTTRVYHKAKHVKVWCPRPPRAVEYTHTHVTNYKSTTR 840 841 EVKTAIRPRATIKTAGPSDMYVHVGNLIYRNLHLFNSDIHDSISVSYSSDLVIYRTNTTG 900 901 DDYIPTCDCTDATYFCKHKNRYYPIKVTSHDWYEIQESEYYPKHIQYNLLIGEGPCEPGD 960 961 CGGKLLCKHGVIGIITAGGEGHVAFIDLRHFHCAEEQGITDYIHMLGEAFGSGFVDSVKD 1020 1021 QINAINPINNISRKIVKWILRIISAMVVIIRNSSDPQTIIATLTLIGCSGSPWRFLKEKF 1080 1081 CKWTQLNYIHKESDSWLKKFTEMCNAARGLEWIGNKISKFIEWMKSMLPQAQLKIKYLNE 1140 1141 LKKLNLLEKQIEHLRIADSSTQEKIKCEIDTLHDLSCKFLPLYASEAKRIKVLYNKCNVI 1200 1201 IKQKKRCEPVAVVIHGEPGAGKSMTTNFLARMITNDSDIYSLPPDPKYFDGYDQQSVVIM 1260 1261 DDIMQNPSGDDMTLFCQMVSSVTFIPPMADLPDKGKPFDSRFVLCSTNHSMLAPPTITSL 1320 1321 PAMNRRFYLDLDIVVSEKYKDQQGKLNVAAAFQPCDVNAKIGNARCCPFICGKAVMFKDR 1380 1381 NTCQSYTLAQVYNHILEEDRRRRQVVDVMSAIFQGPISLEXPPPAAISDLLQSVRTPEVI 1440 1441 KYCEDNKWIIPAGCRIERDLNIANTIITIIANVISISGIIYVIYKLFCTLQGPYSGEPKQ 1500 1501 RTKIPERRVVAQGPEEEFGRSLIKHNSCVVTTQNGKFTGLGIYDRTIIIPTHADPGKEVQ 1560 1561 IDGISTKVEDSYDLYNKDGIKLEITVLKLQRNEKFRDIRKYIPEKEDDYPECNLALSANQ 1620 1621 PETTIISVGDVVSYGNILLSGNQTARMLKYNYPTKSGYCGGILYKIGQVLGIHVGGNGRD 1680 1681 GFAAMLLRSYFSETQGQITISKPVVELGLPSIHTPSKTKLQPSVFHDVFPGSKEPAVLSD 1740 1741 NDPRLEVDFKQALFSKYKGNNECAMNEHIKVAVSHYSAQLHTLDVDPRPITVEDSVFGVE 1800 1801 GLEALDLNTSAGYPYVTMGIKKKDLIDNRAKDLTKLKIAMDKYGVDLPMVTFLKDELRKK 1860 1861 EKISAGKTRVIEASSVNDTVLFRSVYGNLFSKFHLNPGIITGSAVGCDPETFWSKIPVML 1920 1921 DGECIMAFDYTNYDGSIHPVWFDALKLVLANLSFRTDLIDRLCKSKHIFKGTYYEVEGGV 1980 1981 PSGCSGTSIFNTMINNVIIRTLVLDAYKNIDLDKLKIIAYGDDVIFSYKYQLDMEAIALE 2040 2041 GVKYGLTITPADKSSIFKKLDYSNITFLKRGFRQDEKHNFLIHPTFPIDEIHESIRWTKK 2100 2101 PSQMQEHVLSLCHLMWHNGRDVYTQFERRIRSVSAGRALYIPPYDLLLHEWYEKF 2155 >MER0192540 - poliovirus capsid VP0-type self-cleaving protein [N08.001] peptidase unit: 2-333 ( active site residue(s): 69 ) (human rhinovirus 33) (Source: EMBL nucleotide FJ445128) 1 MGAQVSRQNVGTHSTQNAVSNGSSLNYFNINYFKDAASSGASKLEFSQDPSKFTDPVKDV 60 61 LEKGIPTLQSPTVEACGYSDRIIQITRGDSTITSQDVANAVVGYGVWPHYLTPQDATAID 120 121 KPSRPDTSSNRFYTLASKEWDFNSKGWWWKLPDALKDMGIFGENMFYHFLGRSGYTVHVQ 180 181 CNASKFHQGTLIVAMIPEHQLASATTGNATAGYNLTHPGEAGRDVSPKTRENIDKQPSDD 240 241 AWLNFDGTLLGNITVYPHQLINLRSNNSATIIVPYVNAVPMDSMLRHNNWSLVIIPICPL 300 301 ESVPASTVPITISISPMCAEFSGARAAARNQGLPVFITPGSGQFMTTDDFQSPSALPWFH 360 361 PTREISIPGQVKNLVELCQIDTLIPINSTTANNDNTSIYTVTLEKQTNLAQEVFAIKVDI 420 421 ASNPLATTLIGEIASYFTHWTGSVRFSFLFCGTANTTLKLLLAYTPPGIRKPISRKEAML 480 481 GTHVVWDVGLQSTMSMVVPWVSASHFRNTTPDTYSLAGYVTCWYQTSLVVPSSTPITAKM 540 541 LCFVSGCKDFCLRMARDTNLHLQSGIITQNPVENYIEEVLNEVLVVPNIRESQATTSNSA 600 601 PALDAAETGHTNNVQPEDMIETRYVQTSQTLDEMSVESFLGRSGCIHMSKLVVKYEDYNE 660 661 KKNFMTWKINLQEMAQIRRKFEMFTYARFDSEITLVPSIAAQGDDVGHVVMQYMYVPPGA 720 721 PAPEKRDDYTWQSGTNASVFWQYGQTYPRFSLPFLSIASAYYMFYDGYDGDQPNSRYGNM 780 781 VTNDMGTLCSRIVTDNHKHPIEVTTRVYHKAKHVKVWCPRPPRAVEYTHTHVTNYKSTTR 840 841 EVKTAIRPRATIKTAGPSDMYVHVGNLIYRNLHLFNSDIHDSISVSYSSDLVIYRTNTTG 900 901 DDYIPTCDCTDATYFCKHKNRYYPIKVTSHDWYEIQESEYYPKHIQYNLLIGEGPCEPGD 960 961 CGGKLLCKHGVIGIITAGGEGHVAFIDLRHFHCAEEQGITDYIHMLGEAFGSGFVDSVKD 1020 1021 QINAINPINNISRKIVKWILRIISAMVVIIRNSSDPQTIIATLTLIGCSGSPWRFLKEKF 1080 1081 CKWTQLNYIHKESDSWLKKFTEMCNAARGLEWIGNKISKFIEWMKSMLPQAQLKIKYLNE 1140 1141 LKKLNLLEKQIEHLRIADSSTQEKIKCEIDTLHDLSCKFLPLYASEAKRIKVLYNKCNVI 1200 1201 IKQKKRCEPVAVVIHGEPGAGKSMTTNFLARMITNDSDIYSLPPDPKYFDGYDQQSVVIM 1260 1261 DDIMQNPSGDDMTLFCQMVSSVTFIPPMADLPDKGKPFDSRFVLCSTNHSMLAPPTITSL 1320 1321 PAMNRRFYLDLDIVVSEKYKDQQGKLNVAAAFQPCDVNAKIGNARCCPFICGKAVMFKDR 1380 1381 NTCQSYTLAQVYNHILEEDRRRRQVVDVMSAIFQGPISLEXPPPAAISDLLQSVRTPEVI 1440 1441 KYCEDNKWIIPAGCRIERDLNIANTIITIIANVISISGIIYVIYKLFCTLQGPYSGEPKQ 1500 1501 RTKIPERRVVAQGPEEEFGRSLIKHNSCVVTTQNGKFTGLGIYDRTIIIPTHADPGKEVQ 1560 1561 IDGISTKVEDSYDLYNKDGIKLEITVLKLQRNEKFRDIRKYIPEKEDDYPECNLALSANQ 1620 1621 PETTIISVGDVVSYGNILLSGNQTARMLKYNYPTKSGYCGGILYKIGQVLGIHVGGNGRD 1680 1681 GFAAMLLRSYFSETQGQITISKPVVELGLPSIHTPSKTKLQPSVFHDVFPGSKEPAVLSD 1740 1741 NDPRLEVDFKQALFSKYKGNNECAMNEHIKVAVSHYSAQLHTLDVDPRPITVEDSVFGVE 1800 1801 GLEALDLNTSAGYPYVTMGIKKKDLIDNRAKDLTKLKIAMDKYGVDLPMVTFLKDELRKK 1860 1861 EKISAGKTRVIEASSVNDTVLFRSVYGNLFSKFHLNPGIITGSAVGCDPETFWSKIPVML 1920 1921 DGECIMAFDYTNYDGSIHPVWFDALKLVLANLSFRTDLIDRLCKSKHIFKGTYYEVEGGV 1980 1981 PSGCSGTSIFNTMINNVIIRTLVLDAYKNIDLDKLKIIAYGDDVIFSYKYQLDMEAIALE 2040 2041 GVKYGLTITPADKSSIFKKLDYSNITFLKRGFRQDEKHNFLIHPTFPIDEIHESIRWTKK 2100 2101 PSQMQEHVLSLCHLMWHNGRDVYTQFERRIRSVSAGRALYIPPYDLLLHEWYEKF 2155
